Clinical Trials Browser

Phase 1 × Alemtuzumab × Gynecologic × Clear all

NCT00637390 2016-12-02

A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.

Phase 1 Terminated

Fallopian Tube Neoplasms, Ovarian Neoplasms